Genomics | News

APR.14
2023

Event News

Olink Proteomic Web Seminar: “New Product Introduction” Using Olink InSight to visualize protein interactive platform and build exclusive Olink Flex sets.

On Friday, April 28, genomics will hold the 2023 Genomics “Olink Proteomic Web Seminar from 15:00PM to 16:00PM, discussing the topic: “New Product Introduction” Using Olink InSight to visualize protein interactive platform and build exclusive Olink Flex sets”. Come join us and register online for the webinar!

Olink蛋白質體學網路研討會：《新品介紹》運用Olink InSight 視覺化蛋白質互動平台打造Olink Flex專屬套組

研討會主題

Olink Proteomics為一種突破性的技術，在精準蛋白質體學研究中發揮重要功能，為多體學研究提供了新的選擇，高效準確的同時檢測多種重要生物標誌物，其核心為「Proximity Extension Assay (PEA)」技術，中文稱為「鄰近延伸分析技術」，結合了蛋白和抗體免疫反應與寡核苷酸擴增的兩種技術，大大地提升了偵測蛋白的靈敏度、專一性、實現高通量分析以及以超低檢體量(1μl)去進行實驗，可用於疾病預測、診斷及預後，病例分層，基礎研究，生物標記物 (protein biomarker) 深入篩選，新藥靶點 (pQTLs) 等研究中，進而達成精準醫學的目標。

Olink Flex 自選套組可以從~200個經過全面驗證的炎症相關蛋白清單中輕鬆挑選15-21種製成套組，搭配Olink InSight 視覺化蛋白質數據平台做到高組合度的彈性運用，搭配平台的多項互動功能賦予多組學數據更多視角。

活動日期

日期：2023年4月28日 (星期五)

時間：15：00-16：00

講者

基龍米克斯產品管理部黃禹馨

本次研討會將獲得以下資訊

1. Olink Proteomics 產品與原理介紹

2. 新品資訊：Olink Flex 自選套組規格與內容

3. 新品資訊：免費Olink InSight 視覺化蛋白質數據平台功能簡介

4. 如何使用Olink InSight 視覺化蛋白質數據平台打造專屬Olink Flex蛋白質套組

報名連結：https://www.surveycake.com/s/alPNp

報名截止日：2023 年 4 月 26 日 17:00 止

請於網路報名時填寫正確可用之 E-mail，活動前1-2天 (4/26 - 4/27) 會由主辦單位將「網路研討會連結」以 E-mail 方式告知。

Genomics Supports the First Smart Vending Machine for Suspended Meal Charity

Genomics BioSci & Tech. Co. Ltd., Taiwan’s leading genetic sequencing company (hereafter referred to as “Genomics”, stock code: 4195), announced today (18th) the donation of NT$200,000 to the “Suspended Meal Initiative”, the first charity event promoted by the Kuo Hung Chih Sports Association, with the hope that children in remote regions or disadvantaged can receive adequate nutrition while receiving baseball training, allowing them to practice without distractions.

APR.18
2023

Genomics’ Earnings Per Share (EPS) in the previous year was NT$1.15, plans to increase capital expenditure and aims to distribute dividends of NT$0.3

Benefiting from the increased demands of testing services and equipment procurement from the scientific research organizations and the contributions from the sales of the newly added agency of COVID-19 rapid screening products, the consolidated revenue of Genomics for the previous year was NT$419 million, an annual growth of 7.45%. In terms of profits, due to the investment in the construction of GMP plant and expenditures on expansion of R&D teams, the core business has experienced losses, but with upgraded laboratory equipment and process optimization, the gross margin has increased from 28% in 2021 to 32% in 2022. In addition, the profit from the disposal of reinvested stocks pushed up the net profit attributable to the parent company's owners to NT$71.59 million, which is a significant increase of 282% from the previous year, and the after-tax earnings per share (EPS) was NT$1.15.

MAR.15
2023

Explore Other News

goldennet

Olink Proteomic Web Seminar: “New Product Introduction” Using Olink InSight to visualize protein interactive platform and build exclusive Olink Flex sets.

Olink蛋白質體學網路研討會：《新品介紹》 運用Olink InSight 視覺化蛋白質互動平台打造Olink Flex專屬套組

Other News

Genomics Supports the First Smart Vending Machine for Suspended Meal Charity

Genomics’ Earnings Per Share (EPS) in the previous year was NT$1.15, plans to increase capital expenditure and aims to distribute dividends of NT$0.3

Olink蛋白質體學網路研討會：《新品介紹》運用Olink InSight 視覺化蛋白質互動平台打造Olink Flex專屬套組